MicroBase Technology Corp.

TPEX:3184 Stock Report

Market Cap: NT$1.0b

MicroBase Technology Past Earnings Performance

Past criteria checks 5/6

MicroBase Technology has been growing earnings at an average annual rate of 49.4%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 10.2% per year. MicroBase Technology's return on equity is 10.7%, and it has net margins of 29.6%.

Key information

49.4%

Earnings growth rate

49.9%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-10.2%
Return on equity10.7%
Net Margin29.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Is MicroBase Technology (GTSM:3184) Using Debt In A Risky Way?

Apr 11
Is MicroBase Technology (GTSM:3184) Using Debt In A Risky Way?

Is MicroBase Technology (GTSM:3184) Using Too Much Debt?

Dec 01
Is MicroBase Technology (GTSM:3184) Using Too Much Debt?

Revenue & Expenses Breakdown

How MicroBase Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:3184 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24217645319
31 Mar 24206515320
31 Dec 23195385220
30 Sep 23193315121
30 Jun 23190245121
31 Mar 23186155122
31 Dec 2218265223
30 Sep 22183-125430
30 Jun 22184-315537
31 Mar 22199-345843
31 Dec 21213-376150
30 Sep 21226-456655
30 Jun 21239-527160
31 Mar 21244-637669
31 Dec 20250-748077
30 Sep 20261-628277
30 Jun 20273-518477
31 Mar 20269-508674
31 Dec 19265-498771
30 Sep 19297-178872
30 Jun 19329158972
31 Mar 19326-18773
31 Dec 18324-188574
30 Sep 18244-728076
30 Jun 18165-1267678
31 Mar 18150-1227475
31 Dec 17136-1187272
30 Sep 17137-1377370
30 Jun 17139-1567467
31 Mar 17125-1597465
31 Dec 16111-1627463
30 Sep 16108-1367058
30 Jun 16106-1116652
31 Mar 16106-976347
31 Dec 15106-836042
30 Sep 15104-1106039
30 Jun 15102-1375935
31 Mar 1597-1495736
31 Dec 1491-1625536
30 Sep 1496-1275334
30 Jun 14101-925133
31 Mar 14181-375531
31 Dec 13261186030

Quality Earnings: 3184 has high quality earnings.

Growing Profit Margin: 3184's current net profit margins (29.6%) are higher than last year (12.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 3184 has become profitable over the past 5 years, growing earnings by 49.4% per year.

Accelerating Growth: 3184's earnings growth over the past year (168.6%) exceeds its 5-year average (49.4% per year).

Earnings vs Industry: 3184 earnings growth over the past year (168.6%) exceeded the Medical Equipment industry 1.7%.


Return on Equity

High ROE: 3184's Return on Equity (10.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies